Let’s discuss! #gyncsm #medmastodon
https://www.nytimes.com/2023/02/01/health/ovarian-cancer-fallopian-tubes.html?referringSource=articleShare

RT @TumorBoardTues
Next #TumorBoardTuesday 🧵 you may have missed

⏪ Rewind ⏪ to our fabulous fireside chat featuring a brief discussion on safety & management of #EndometrialCancer with @DrMMurphy @drteplinsky

Sit back & listen while grabbing a bite to eat.
#gyncsm https://twitter.com/tumorboardtues/status/1616239139082625024

Next #TumorBoardTuesday 🧵 you may have missed

⏪ Rewind ⏪ to our fabulous fireside chat featuring a brief discussion on safety & management of #EndometrialCancer with @DrMMurphy @drteplinsky

Sit back & listen while grabbing a bite to eat.
#gyncsm
---
RT @TumorBoardTues
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu gra…
https://twitter.com/TumorBoardTues/status/1616239139082625024

RT @TumorBoardTues
4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇

RT @TumorBoardTues
3/#TumorBoardTuesday #gyncsm #OncTwitter

🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
🤯Feeling left behind?

Don't fret, it's here📍
https://twitter.com/BonumCe/status/1615519240542646275

RT @TumorBoardTues
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://twitter.com/i/broadcasts/1yoJMZrrqbNxQ

RT @TumorBoardTues
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://twitter.com/i/broadcasts/1yoJMZrrqbNxQ

RT @TumorBoardTues
💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://twitter.com/i/broadcasts/1yoJMZrrqbNxQ

RT @TumorBoardTues
3/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

🟠Earn 🆓 #CME 🏆
🟠#CME ℹ️🔗http://bit.ly/3YRDkog

📸 Faculty disclosures & important CME info 👇

RT @TumorBoardTues
3/#TumorBoardTuesday #gyncsm #OncTwitter

🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
🤯Feeling left behind?

Don't fret, it's here📍
https://twitter.com/BonumCe/status/1615519240542646275

RT @TumorBoardTues
4/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

⌚️Understanding timing of onset helps us better understand, differentiate, & manage TKI & ICI-related AEs 👇

RT @TumorBoardTues
5/ Thanks #TumorBoardTuesday & #gyncsm!

🏆Claim #CME http://bit.ly/3hYxu3R
⬇️Answer #PostTest👇

🔴#PostTest Q1️⃣
📊Diarrhea, nausea, & vomiting are common GI tox associated w pembro + lenvatinib combo tx
🔴Which other tox may occur if these GI tox r not effectively managed?

RT @TumorBoardTues
6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
#CME 🔗http://bit.ly/3hYxu3R

🔴#PostTest Q 2️⃣
📊During tx w pembro + lenva, pt develops grd 3 diarrhea
🛑Lenva held
💊Loperamide Rx
Grade3️⃣diarrhea persists

🔴Which is the appropriate next step for this pt?

RT @TumorBoardTues
7/#TumorBoardTuesday #GynCSM

🔴#PostTest Q3️⃣
📊Pt receiving pembro + lenva combo for past 12m
🗓@ f/u presented w persistently high levels of TSH
🟥Lenva withheld, but TSH levels remain high (>10mIU/L)

🔴What is the most appropriate next step in the mgmt of this pt?

RT @TumorBoardTues
8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

#CME🔗http://bit.ly/3hYxu3R

🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

RT @TumorBoardTues
2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#CME🔗http://bit.ly/3YRDkog

🟢#PreTest Q 1️⃣
📊Diarrhea, nausea, & vomiting are common GI toxicities associated w pembro + lenvatinib combo therapy

🟢Which other tox may occur if these GI toxicities are not effectively managed?

RT @TumorBoardTues
3/#TumorBoardTuesday #GynCSM #EndometrialCancer
#CME🔗http://bit.ly/3YRDkog

🟢#PreTest Q 2️⃣
📊During tx w pembro + lenvatinib, pt develops grade 3 diarrhea
🛑Lenva held
💊Loperamide Rx
Grade3️⃣diarrhea persists

🟢What is the next step for this pt?
(cs=corticosteroid)

RT @TumorBoardTues
4/#TumorBoardTuesday #GynCSM
🟢#PreTest Q 3️⃣

📊Pt receiving pembro + lenva combo for past 12m
🗓@ f/u presented w persistently high levels of TSH
🟥Lenva withheld, but TSH levels remain high (>10mIU/L)

🟢What is the most appropriate next step in the mgmt of this pt?

RT @TumorBoardTues
5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
#CME 🔗http://bit.ly/3YRDkog

🟢#PreTest Q 4️⃣
📊During treatment w pembro + lenva, pt develops grade 3 HTN
🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

#CME🔗http://bit.ly/3hYxu3R

🔴#PostTest Q4️⃣
During treatment w pembro + lenva, pt develops grade 3 HTN
🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)